Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Zapata-Cobo

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pharmaceutics|October 27, 2022
Genotyping of <i>UGT1A1*</i>80 as an Alternative to <i>UGT1A1*</i>28 Genotyping in SpainAdrián Bravo-Gómez, Sara Salvador-Martín, Paula Zapata-Cobo, et al.
Anales De Pediatria|January 14, 2026
Update on pharmacogenetics in pediatricsIrene Taladriz-Sender, Sara Salvador-Martín, Paula Zapata-Cobo, et al.
International Journal of Molecular Sciences|October 26, 2024
An Inexpensive and Quick Method for Genotyping of HLA Variants Included in the Spanish Pharmacogenomic Portfolio of National Health SystemIrene Taladriz-Sender, Gina Hernández-Osio, Paula Zapata-Cobo, et al.
International Journal of Molecular Sciences|April 17, 2025
Changes in T Lymphocytes and Cytokines After Anti-TNF Treatment in Pediatric Inflammatory Bowel Disease: Association with Response to Pharmacologic TherapyPaula Zapata-Cobo, Sara Salvador-Martín, Sergio Gil-Manso, et al.
Pharmacological Research|July 20, 2023
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in childrenPaula Zapata-Cobo, Sara Salvador-Martín, Marta Velasco, et al.
Pharmacological Research|September 25, 2023
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in childrenPaula Zapata-Cobo, Sara Salvador-Matín, Marta Velasco, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 24, 2024
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatmentSara Salvador-Martín, Gianluca Rubbini, Perceval Vellosillo, et al.
International Journal of Molecular Sciences|January 21, 2023
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease CohortSara Salvador-Martín, Paula Zapata-Cobo, Marta Velasco, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pharmaceutics|October 27, 2022
Genotyping of <i>UGT1A1*</i>80 as an Alternative to <i>UGT1A1*</i>28 Genotyping in SpainAdrián Bravo-Gómez, Sara Salvador-Martín, Paula Zapata-Cobo, et al.
Anales De Pediatria|January 14, 2026
Update on pharmacogenetics in pediatricsIrene Taladriz-Sender, Sara Salvador-Martín, Paula Zapata-Cobo, et al.
International Journal of Molecular Sciences|October 26, 2024
An Inexpensive and Quick Method for Genotyping of HLA Variants Included in the Spanish Pharmacogenomic Portfolio of National Health SystemIrene Taladriz-Sender, Gina Hernández-Osio, Paula Zapata-Cobo, et al.
International Journal of Molecular Sciences|April 17, 2025
Changes in T Lymphocytes and Cytokines After Anti-TNF Treatment in Pediatric Inflammatory Bowel Disease: Association with Response to Pharmacologic TherapyPaula Zapata-Cobo, Sara Salvador-Martín, Sergio Gil-Manso, et al.
Pharmacological Research|July 20, 2023
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in childrenPaula Zapata-Cobo, Sara Salvador-Martín, Marta Velasco, et al.
Pharmacological Research|September 25, 2023
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in childrenPaula Zapata-Cobo, Sara Salvador-Matín, Marta Velasco, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 24, 2024
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatmentSara Salvador-Martín, Gianluca Rubbini, Perceval Vellosillo, et al.
International Journal of Molecular Sciences|January 21, 2023
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease CohortSara Salvador-Martín, Paula Zapata-Cobo, Marta Velasco, et al.
Pageof 1